Stock-Based Compensation | Stock-Based Compensation Stock-based Compensation Cost The following table shows the stock-based compensation cost by award type for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Equity classified awards Restricted stock units $ 10,640 $ 8,424 $ 19,019 $ 15,250 Stock options 520 906 1,146 1,918 Class B common stock 1,383 2,148 3,272 4,810 Liability classified awards 14 22 26 (208) Total stock-based compensation $ 12,557 $ 11,500 $ 23,463 $ 21,770 The following table sets forth the total stock-based compensation cost included in the Company’s condensed consolidated statements of operations and comprehensive income or capitalized to assets for the periods indicated: Three Months Ended June 30, Six Months Ended June 30, 2023 2022 2023 2022 (in thousands) Cost of revenue Connected machines $ 191 $ 9 $ 374 $ 12 Subscriptions 214 107 329 159 Accessories and materials 249 — 524 — Total cost of revenue 654 116 1,227 171 Research and development 4,717 4,915 8,623 8,926 Sales and marketing 3,001 3,255 6,206 6,123 General and administrative 3,514 2,116 6,251 4,140 Total stock-based compensation expense $ 11,886 $ 10,402 $ 22,307 $ 19,360 Capitalized for software development costs 545 612 975 1,153 Capitalized to inventories 126 486 181 1,257 Total stock-based compensation $ 12,557 $ 11,500 $ 23,463 $ 21,770 As of June 30, 2023, there was $119.7 million of unrecognized stock-based compensation cost related to service-based awards which is expected to be recognized over a weighted-average period of 2.7 years. The total unrecognized compensation expense related to unvested performance-based restricted stock units (“PRSUs”) was $147.2 million as of June 30, 2023. 2021 Equity Incentive Plan In March 2021, the Company’s 2021 Equity Incentive Plan became effective. The 2021 Equity Incentive Plan provides for the grant of incentive stock options to employees and for the grant of nonstatutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units and performance shares to our employees, directors and consultants and our parent and subsidiary corporations’ employees and consultants. As of June 30, 2023, 41,746,040 shares of Class A common stock were reserved for issuance under this plan including shares reserved for previously granted awards discussed below as well as shares reserved for issuance of future awards under the plan. A summary of the Company’s service-based restricted stock unit (“RSU”) activity under the 2021 Equity Incentive Plan is as follows: Number of RSUs Weighted- Average Grant Date Fair Value (per share) Outstanding at December 31, 2022 6,364,022 $ 18.16 Granted 3,722,994 $ 10.60 Dividend equivalent grants 223,415 — Vested (1,549,421) $ 18.53 Forfeited / cancelled (266,194) $ 15.52 Outstanding at June 30, 2023 8,494,816 $ 14.83 In 2022, the Company granted PRSUs under the 2021 Equity Incentive Plan to certain employees that represent shares potentially issuable in the future. The PRSUs vest in two equal tranches subject to the Company achieving cumulative adjusted earnings per share over eight quarters of $4.93 per share and $6.16 per share, respectively, at any point during the 5-year performance period, subject to employees remaining with the Company through the vesting date. Adjusted earnings per share means GAAP net income adjusted to exclude income tax expenses, as well as stock-based compensation expense and payroll tax expense specifically related to the PRSU awards. A summary of the Company’s PRSU activity under the 2021 Equity Incentive Plan is as follows: Number of PRSUs (a) Weighted- Average Grant Date Fair Value (per share) Outstanding at December 31, 2022 6,295,000 $ 23.32 Dividend equivalent grants 224,351 $ — Forfeited / cancelled (205,564) $ 23.37 Outstanding at June 30, 2023 6,313,787 $ 23.32 a. Represents the maximum number of PRSUs assuming all performance targets are achieved. The expense recognized each period for these PRSUs is primarily dependent upon the Company’s estimate of the probability of achieving the performance targets. At June 30, 2023, the Company determined it was not probable any performance conditions would be achieved so no stock-based compensation was recorded for these PRSUs during the six months ended June 30, 2023. Options under the 2021 Equity Incentive Plan have a contractual term of 10 years. The exercise price of an incentive stock option and non-qualified stock option shall not be less than 100% of the fair market value of the shares on the date of grant. A summary of the Company’s stock option activity under the 2021 Equity Incentive Plan is as follows: Number of Options Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value (in thousands) Outstanding at December 31, 2022 3,142,911 $ 20.00 4.6 $ — Forfeited / cancelled (92,560) $ 20.00 Outstanding at June 30, 2023 3,050,351 $ 20.00 4.0 $ — Vested and exercisable at June 30, 2023 2,281,992 $ 20.00 3.8 $ — During the six months ended June 30, 2023 and 2022, no options were granted. Certain employees received restricted stock unit equivalents (“RSU equivalents”) which upon vesting are settled for a cash payment equal to the difference between the Company’s stock price on the vesting date less the base price specified at the time of the grant. As of June 30, 2023, the total recognized liability for these awards was immaterial. Unvested Class B Common Stock The Company’s unvested Class B common stock resulted from the Corporate Reorganization and is not part of the 2021 Equity Incentive Plan. Activity related to Class B common stock subject to future vesting for the six months ended June 30, 2023 is as follows: Number of Unvested Shares Weighted- Average Grant Date Fair Value (per share) Outstanding at December 31, 2022 4,655,214 $ 20.00 Vested (1,935,246) $ 20.00 Forfeited / cancelled (303,804) $ 20.00 Outstanding at June 30, 2023 2,416,164 $ 20.00 Options to Purchase Class B Common Stock The Company’s options to purchase Class B common stock resulted from the Corporate Reorganization and are not part of the 2021 Equity Incentive Plan. A summary of the Company stock option activity for the options to purchase shares of Class B common stock is as follows: Number of Options Weighted- Average Exercise Price Weighted- Aggregate Intrinsic Value (in thousands) Outstanding at December 31, 2022 358,000 $ 9.04 2.8 $ 82 Exercised (22,000) 9.04 Forfeited / cancelled (40,000) $ 9.04 Outstanding at June 30, 2023 296,000 $ 9.04 2.3 $ 27 Vested and exercisable at June 30, 2023 296,000 $ 9.04 2.3 $ 27 During the six months ended June 30, 2023 and 2022, the total intrinsic value of options exercised was immaterial. 2021 Employee Stock Purchase Plan In March 2021, the Company’s 2021 Employee Stock Purchase Plan (“2021 ESPP”) became effective. Subject to any limitations contained therein, the 2021 ESPP allows eligible employees to contribute, through payroll deductions, up to 15% of their eligible compensation to purchase the Company’s Class A common stock at a discounted price per share. As of June 30, 2023, 8,422,446 shares of our Class A common stock were available for sale under the 2021 ESPP. No offerings have been authorized to date by the administrator under the 2021 ESPP. If the administrator authorizes an offering period under the 2021 ESPP, the administrator will establish the duration of offering periods and purchase periods, including the starting and ending dates of offering periods and purchase periods, provided that no offering period may have a duration exceeding 27 months. |